These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9681701)

  • 1. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
    Grupp C; Schmidt F; Braun F; Lorf T; Ringe B; Müller GA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1629-31. PubMed ID: 9681701
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
    Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
    Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
    Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
    Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonrecurrent hemolytic uremic syndrome (HUS de novo) as cause of acute renal failure after renal transplant.
    Mazzali M; Dias EP; Ribeiro-Alves MA; Homsi E; Alves-Filho G
    Ren Fail; 1997 Mar; 19(2):271-7. PubMed ID: 9101603
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
    Pratt G; Kennedy B; Smith G
    BMJ; 1999 Jul; 319(7201):54; author reply 54-5. PubMed ID: 10390471
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
    Myers JN; Shabshab SF; Burton NA; Nathan SD
    J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renovascular elements of the cyclosporine injury.
    Curtis JJ
    Transplant Proc; 1996 Aug; 28(4):2094-6. PubMed ID: 8769164
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.
    Kohli HS; Sud K; Jha V; Gupta KL; Minz M; Joshi K; Sakhuja V
    Nephrol Dial Transplant; 1998 Nov; 13(11):2940-2. PubMed ID: 9829509
    [No Abstract]   [Full Text] [Related]  

  • 10. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
    Guella A; Daoud M; Al Dayel A
    Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750
    [No Abstract]   [Full Text] [Related]  

  • 11. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
    Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
    Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.
    Agarwal DK; Gulati S; Mehta A; Kumar A; Sharma RK; Mehta B; Gupta A; Gupta RK
    Nephrol Dial Transplant; 2000 Dec; 15(12):2064-5. PubMed ID: 11096161
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
    Lapointe M; Baillie GM; Bhaskar SS; Richardson MS; Self SE; Baliga PK; Rajagopalan PR
    Clin Transplant; 1999 Dec; 13(6):526-30. PubMed ID: 10617244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome.
    Richardson D; Jones CH; Newstead CG; Will EJ; Lodge JP
    Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease.
    Chatterjee A; D'Souza RJ
    Nephrol Dial Transplant; 1997 Dec; 12(12):2799-800. PubMed ID: 9430907
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemolytic uremic syndrome after renal transplantation: immunosuppressive therapy with rapamycin.
    Heering P; Deppe CE; Farokhzad F; Helmchen U; Grabensee B
    Nephron; 2002 May; 91(1):177. PubMed ID: 12021541
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
    Furmańczyk A; Komuda-Leszek E; Durlik M
    Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic uraemic syndrome associated with OKT3.
    Morris-Stiff G; Evans M; Baboolal K; Balaji V; Moore R; Jurewicz A; Lord R
    Transpl Int; 1996; 9(5):522-3. PubMed ID: 8875800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.